FindMyRecallSubscribe
Class I: serious health riskOngoing

Hospira 8.4% Sodium Bicarbonate Injection Recall

8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx…

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Jun 1, 2016
Recall ID
D-0865-2016
Check your lot numberHow we source this data

Summary

Hospira recalled 8.4% Sodium Bicarbonate Injection starting Mar 18, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-0865-2016 on Jun 1, 2016. Reason: Presence of Particulate Matter: particulate matter identified as an insect in one vial. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: particulate matter identified as an insect in one vial.

Product description

8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02

Lot numbers, UPCs & expiration codes

Lot # 56-148-EV, Exp 8/1/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0865-2016
Classification
Class I
Status
Ongoing
Recall initiated
Mar 18, 2016
FDA report date
Jun 1, 2016
Quantity
72,000 units
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0865-2016, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Ongoing
Country
United States
Event ID
73653
Address
275 N Field Dr
Code information
Lot # 56-148-EV, Exp 8/1/2017
Postal code
60045-2579
Report date
Jun 1, 2016
Product type
Drugs
Recall number
D-0865-2016
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
72,000 units
Reason for recall
Presence of Particulate Matter: particulate matter identified as an insect in one vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL), 50 mL, Rx only, Hospira Inc, Lake Forest, IL 60045, NDC 0409-6625-02
Distribution pattern
Nationwide
Recall initiation date
Mar 18, 2016
Initial firm notification
Letter
Center classification date
May 23, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0865-2016, published Jun 1, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls